Year in preview: antitrust on a “blue wave”

For the first time in eight years, Democrats control the US House of Representatives and its antitrust subcommittee. With that comes a bully pulpit, but also a big stick of investigation and potentially legislation.

• DOJ’s AT&T appeal may be undercut by a trial concession
• Google and the transatlantic antitrust abyss

Preface

• Introduction
• FTC v Sysco/US Foods

Q&A with Cleary’s Kathleen Bradish

Kathleen Bradish returned to Cleary Gottlieb Steen & Hamilton as counsel last autumn after almost three-and-a-half years at the Department of Justice’s antitrust division, where she was assistant chief for the international section. She already had nearly a decade of experience at Cleary, where she represented pharmaceutical companies including Santarus, Abbott Laboratories and GlaxoSmithKline. Bradish will be speaking at the inaugural GCR Live Pharmaceuticals conference on 28 February in Washington, DC.

• An interview with Tim Wu
• Q&A with Nokia’s Eeva Hakoranta
• Q&A with Noah Brumfield
• Q&A with Jay Jurata

Litigators of the Week: White & Case

The overturning of class certification for indirect purchasers of Asacol may reshape how some class actions are formed, as a defence strategy of aggressive discovery on plaintiffs bore fruit in a successful appeal.

• Litigators of the Week: Joe Presta and Robert Rowan
• Litigators of the Week: Counsel to the AndroGel defendants

Hot Docs – Hovenkamp, hospital-home bias and a healthy dose of judicial review

While the recent heatwave may have you inside by the air-conditioning all day, we have collected the hottest docs in antitrust to keep you entertained.

• Hot Docs: The ups and downs of horizontal shareholding and vertical enforcement
• Hot Docs: Dons and Bert and Roger and Herb